Has Jeffrey Eaton, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,777 in general payments to Jeffrey Eaton, MD across 308 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jeffrey Eaton, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jeffrey Eaton, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jeffrey Eaton, MD

MOHS-Micrographic Surgery · San Diego, CANPI 1316913650

Payments from drug & device makers

$6,777in general payments, 2019–2025

Across 308 payments — averaging $22.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$803
Pfizer$548
Sun Pharmaceutical Industries Inc.$458
AbbVie$436
GSK$413
Johnson & Johnson$404
plus $4K from 34 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	34	$803
Pfizer	26	$548
Sun Pharmaceutical Industries Inc.	19	$458
AbbVie	19	$436
GSK	21	$413
Johnson & Johnson	13	$404
Regeneron Healthcare Solutions, Inc.	10	$374
Ortho Dermatologics, A Division Of Bausch Health US, LLC	28	$369
LEO Pharma Inc.	19	$363
Galderma Laboratories, L.p.	17	$306
Stryker	8	$267
Amgen	9	$222
Genentech USA, Inc.	12	$207
Arcutis Biotherapeutics, Inc.	9	$194
Incyte Corporation	10	$173
Optinose US, Inc.	7	$140
Sanofi-aventis U.S. LLC	5	$106
Almirall LLC	5	$93
ANI Pharmaceuticals, Inc.	3	$84
Prugen, Inc. Pharmaceuticals	1	$83
Journey Medical Corporation	3	$70
Helsinn Therapeutics (U.S.), Inc.	3	$70
UCB, Inc.	2	$60
Smith+Nephew	3	$57
Integra Lifesciences Corporation	2	$54
Lilly USA, LLC	2	$53
Dermavant Sciences, Inc.	2	$44
Intersect ENT, Inc.	1	$39
Biofrontera Inc.	2	$37
Revance Therapeutics, Inc.	1	$33
VYNE Pharmaceuticals Inc.	2	$33
Merz North America, Inc.	1	$30
E.r. Squibb & Sons, L.L.C.	1	$29
Neurent Medical Limited	1	$25
Acera Surgical, Inc.	1	$23
Bristol Myers Squibb	1	$18
Apyx Medical Corporation	2	$18
Mission Pharmacal Company	1	$15
Dermira, Inc.	1	$15
Misonix Inc	1	$13

How this compares

$6,777 in reported general payments places this provider in the 75th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California →

Medicare billing

Part B allowed, 2024

$719,397

Medicare patients

542

Services billed

1,752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other mohs-micrographic surgery in San Diego

Joseph del PrioreSan Diego$7K
Derek NickersonSan Diego$5K
Michael HammanSan Diego$4K
Michael MortazieOrange$1.2M
Thuzar ShinSacramento$353K
Sarah ArronBurlingame$223K
Christopher Crosbyla Mesa$211K
Abel TorresLoma Linda$136K
Robert ScheinbergOceanside$129K
Sherry RotundaOceanside$99K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →